BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeitler P, Arslanian S, Fu J, Pinhas-Hamiel O, Reinehr T, Tandon N, Urakami T, Wong J, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth. Pediatr Diabetes. 2018;19 Suppl 27:28-46. [PMID: 29999228 DOI: 10.1111/pedi.12719] [Cited by in Crossref: 133] [Cited by in F6Publishing: 142] [Article Influence: 33.3] [Reference Citation Analysis]
Number Citing Articles
1 Tas E, Wooley K, Tas V, Wang YA. Delayed Management of Insulin-Dependent Diabetes Mellitus in Children. J Pediatr Health Care 2023;37:56-62. [PMID: 35977849 DOI: 10.1016/j.pedhc.2022.07.004] [Reference Citation Analysis]
2 Vazeou A, Stergiou GS. Methods for Measuring Blood Pressure and Applications to Diabetes. Biomarkers in Diabetes 2023. [DOI: 10.1007/978-3-031-08014-2_37] [Reference Citation Analysis]
3 Capra ME, Stanyevic B, Giudice A, Monopoli D, Decarolis NM, Esposito S, Biasucci G. The Effects of COVID-19 Pandemic and Lockdown on Pediatric Nutritional and Metabolic Diseases: A Narrative Review. Nutrients 2022;15. [PMID: 36615746 DOI: 10.3390/nu15010088] [Reference Citation Analysis]
4 Li X, Sun T, Du X, Xie X, Shi L. The efficacy and safety of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists in pediatric patients with type 2 diabetes: a systematic review. Journal of Pediatric Endocrinology and Metabolism 2022;35:1457-1463. [DOI: 10.1515/jpem-2021-0533] [Reference Citation Analysis]
5 Chylińska-Frątczak A, Pietrzak I, Michalak A, Wyka K, Szadkowska A. Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity. Front Endocrinol (Lausanne) 2022;13:1061671. [PMID: 36589801 DOI: 10.3389/fendo.2022.1061671] [Reference Citation Analysis]
6 Welters A, Tittel SR, Reinehr T, Weghuber D, Wiegand S, Karges W, Freiberg C, Meissner T, Schloot NC, Holl RW. Clinical characteristics and cardiovascular risk profile in children and adolescents with latent autoimmune diabetes: Results from the German/Austrian prospective diabetes follow-up registry. Pediatr Diabetes 2022;23:1602-12. [PMID: 36334008 DOI: 10.1111/pedi.13450] [Reference Citation Analysis]
7 Mastromauro C, Polidori N, Blasetti A, Comegna L, Chiarelli F, Mohn A, Giannini C. Insulin resistance relates to DKA severity and affects insulin requirement in children with type 1 diabetes at onset. Pediatr Diabetes 2022;23:1613-20. [PMID: 36183171 DOI: 10.1111/pedi.13424] [Reference Citation Analysis]
8 Angley E, Matejin E, Gul S, Rodda C, Longmore DK. Prevalence of type 2 diabetes risk factors, including overweight and obesity, among youth attending hospital‐based paediatric care in Western Melbourne. J Paediatrics Child Health 2022. [DOI: 10.1111/jpc.16283] [Reference Citation Analysis]
9 Kim KY, Kim MS, Lee YJ, Lee YA, Lee SY, Shin CH, Kim JH. Glutamic Acid Decarboxylase and Tyrosine Phosphatase-Related Islet Antigen-2 Positivity among Children and Adolescents with Diabetes in Korea. Diabetes Metab J 2022;46:948-52. [PMID: 35263538 DOI: 10.4093/dmj.2021.0332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bjornstad P, Chao LC, Cree-Green M, Dart AB, King M, Looker HC, Magliano DJ, Nadeau KJ, Pinhas-Hamiel O, Shah AS, van Raalte DH, Pavkov ME, Nelson RG. Youth-onset type 2 diabetes mellitus: an urgent challenge. Nat Rev Nephrol 2022. [PMID: 36316388 DOI: 10.1038/s41581-022-00645-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bensignor MO, Kelly AS, Arslanian S. Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1043650] [Reference Citation Analysis]
12 Lim CYS, Foo YW, Tok CLX, Lim YY, Loke KY, Lee YS, Ng NBH. Screening for metabolic complications of childhood and adolescent obesity: A scoping review of national and international guidelines. Obesity Reviews 2022. [DOI: 10.1111/obr.13513] [Reference Citation Analysis]
13 Zhou F, Deng J, Banfield L, Thabane L, Sadeghirad B, Samaan MC. Pharmacotherapy in paediatric type 2 diabetes mellitus: a protocol for a systematic review and network meta-analysis of randomised trials. BMJ Open 2022;12:e065287. [PMID: 36167361 DOI: 10.1136/bmjopen-2022-065287] [Reference Citation Analysis]
14 Murphy SA, O'Rourke NE, O'Grady MJ. Prepubertal onset of type 2 diabetes in Shashi-Pena syndrome due to ASXL2 mutation. Am J Med Genet A 2022;188:2803-7. [PMID: 35716351 DOI: 10.1002/ajmg.a.62876] [Reference Citation Analysis]
15 Karavanaki K, Paschou SA, Tentolouris N, Karachaliou F, Soldatou A. Type 2 diabetes in children and adolescents: distinct characteristics and evidence-based management. Endocrine 2022. [PMID: 36029440 DOI: 10.1007/s12020-022-03172-y] [Reference Citation Analysis]
16 Mastromauro C, Polidori N, Giannini C. Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes. Curr Opin Pediatr 2022;34:414-22. [PMID: 35836399 DOI: 10.1097/MOP.0000000000001138] [Reference Citation Analysis]
17 Kim HY, Kim JH. Diagnostic and Therapeutic Strategies of Type 2 Diabetes Mellitus in Youth. Ewha Med J 2022;45. [DOI: 10.12771/emj.2022.e3] [Reference Citation Analysis]
18 Yen FS, Wei JC, Liu JS, Hsu CC, Hwu CM. Clinical course of adolescents with type 2 diabetes mellitus: A nationwide cohort study in Taiwan. J Diabetes Investig 2022. [PMID: 35726692 DOI: 10.1111/jdi.13873] [Reference Citation Analysis]
19 Ovsyannikova AK, Zubareva AY. Features of the course of type 2 diabetes mellitus in young people. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-10-57-61] [Reference Citation Analysis]
20 Leister KR, Cilhoroz BT, Rosenberg J, Brown EC, Kim JY. Metabolic syndrome: Operational definitions and aerobic and resistance training benefits on physical and metabolic health in children and adolescents. Diabetes Metab Syndr 2022;16:102530. [PMID: 35709585 DOI: 10.1016/j.dsx.2022.102530] [Reference Citation Analysis]
21 Preechasuk L, Tantasuwan S, Likitmaskul S, Santiprabhob J, Lertbannaphong O, Plengvidhya N, Tangjittipokin W, Nitiyanant W, Lertwattanarak R. Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital - A Tertiary Referral Center. Diabetes Metab Syndr Obes 2022;15:1375-87. [PMID: 35528720 DOI: 10.2147/DMSO.S354787] [Reference Citation Analysis]
22 Wong J, Ross GP, Zoungas S, Craig ME, Davis EA, Donaghue KC, Maple-Brown LJ, McGill MJ, Shaw JE, Speight J, Wischer N, Stranks S. Management of type 2 diabetes in young adults aged 18-30 years: ADS/ADEA/APEG consensus statement. Med J Aust 2022;216:422-9. [PMID: 35430745 DOI: 10.5694/mja2.51482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tamborlane WV, Laffel LM, Shehadeh N, Isganaitis E, Van Name M, Ratnayake J, Karlsson C, Norjavaara E. Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. The Lancet Diabetes & Endocrinology 2022;10:341-50. [DOI: 10.1016/s2213-8587(22)00052-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
24 Jackson S, Creo A, Kumar S. Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth? Curr Atheroscler Rep 2022. [PMID: 35404039 DOI: 10.1007/s11883-022-01020-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Saboo B, Agarwal S, Makkar BM, Chawla R, Ghosh S, Viswanathan V, Gupta S, Kumar CV, Maheshwari A, Sreenivasamurthy L, Sahay RK, Reddy S, Jaggi S, Sharma JK, Panikar V, Moses A, Bhattacharjee B, Jethwani P, Bhandari S, Sawhney JPS, Joshi S, Ray S, Madhu SV, Sethi B. RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-022-01063-6] [Reference Citation Analysis]
26 Močnik M, Marčun Varda N. Cardiovascular Risk Factors in Children. Risk Factors for Cardiovascular Disease 2022. [DOI: 10.5772/intechopen.99729] [Reference Citation Analysis]
27 Stevens P, Hunter J, Molodysky E. The role of hyperinsulinaemia in screening for prediabetes in the adolescent population: A systematic literature review. Diabetes Metab Syndr 2022;16:102445. [PMID: 35305511 DOI: 10.1016/j.dsx.2022.102445] [Reference Citation Analysis]
28 Nwosu BU. The Theory of Hyperlipidemic Memory of Type 1 Diabetes. Front Endocrinol 2022;13:819544. [DOI: 10.3389/fendo.2022.819544] [Reference Citation Analysis]
29 Reinehr T. 13/m mit deutlicher Gewichtszunahme: Vorbereitung auf die Facharztprüfung: Fall 49. Monatsschr Kinderheilkd. [DOI: 10.1007/s00112-022-01437-4] [Reference Citation Analysis]
30 Šumník Z, Konečná P, Venháčová P, Neumann D, Škvor J, Pomahačová R, Strnadel J, Průhová Š, Petruželková L, Vosáhlo J, Kocourková K, Pavlíková M, Cinek O, Čenda ZK. Continuing improvement in metabolic control in Czech children with type 1 diabetes: data from the ČENDA registry (2013-2020). Czech-Slovak Pediatrics 2022;77:64-71. [DOI: 10.55095/cspediatrie2022/008] [Reference Citation Analysis]
31 James S, Maniam J, Cheung PT, Urakami T, von Oettingen J, Likitmaskul S, Ogle G. Epidemiology and phenotypes of diabetes in children and adolescents in non-European-origin populations in or from Western Pacific region. World J Clin Pediatr 2022; 11(2): 173-195 [DOI: 10.5409/wjcp.v11.i2.173] [Reference Citation Analysis]
32 Mohan V, Saboo B, Khader J, Modi KD, Jindal S, Wangnoo SK, Amarnath S. Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines. Clin Med Insights Endocrinol Diabetes 2022;15:11795514221074663. [PMID: 35185350 DOI: 10.1177/11795514221074663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Wu H, Patterson CC, Zhang X, Ghani RBA, Magliano DJ, Boyko EJ, Ogle GD, Luk AO. Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109785] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
34 Vazeou A, Stergiou GS. Methods for Measuring Blood Pressure and Applications to Diabetes. Biomarkers in Diabetes 2022. [DOI: 10.1007/978-3-030-81303-1_37-1] [Reference Citation Analysis]
35 Tommerdahl KL, Shapiro ALB, Nehus EJ, Bjornstad P. Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates. Pediatr Nephrol 2022;37:79-93. [PMID: 33852054 DOI: 10.1007/s00467-021-05050-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
36 Neyman A, Nabhan Z, Woerner S, Hannon T. Pediatric Type 2 Diabetes Presentation During the COVID-19 Pandemic. Clin Pediatr (Phila) 2021;:99228211064030. [PMID: 34875904 DOI: 10.1177/00099228211064030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Hörtenhuber T. Juveniler Typ-2-Diabetes mellitus – eine unterschätzte Hochrisikoerkrankung. J Klin Endokrinol Stoffw 2021;14:145-149. [DOI: 10.1007/s41969-021-00151-y] [Reference Citation Analysis]
38 Şen S, Özalp Kızılay D, Taneli F, Özen Ç, Ertan P, Özunan İ, Yıldız R, Ersoy B. Urinary NGAL is a Potential Biomarker for Early Renal Injury in Insulin Resistant Obese Non-diabetic Children. J Clin Res Pediatr Endocrinol 2021;13:400-7. [PMID: 34013756 DOI: 10.4274/jcrpe.galenos.2021.2021.0020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Shamchuk A, Doulla M, Jetha M. Association possible entre l’acidocétose diabétique et l’utilisation d’un inhibiteur du sodium-glucose co-transporteur 2 chez un jeune de 17 ans atteint de diabète de type 2. CMAJ 2021;193:E1746-9. [PMID: 34782384 DOI: 10.1503/cmaj.202627-f] [Reference Citation Analysis]
40 Middleton T, Constantino M, McGill M, D'Souza M, Twigg SM, Wu T, Thiagalingam A, Chow C, Wong J. An Enhanced SMS Text Message-Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial. J Med Internet Res 2021;23:e27263. [PMID: 34524102 DOI: 10.2196/27263] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Xu J, Pratt K, Chaudhari M, Henry R, Hubbard RA, Siegel R, Eneli I. On a Different Page! Perceptions on the Onset, Diagnosis, and Management of Type 2 Diabetes Among Adolescent Patients, Parents, and Physicians. Glob Pediatr Health 2021;8:2333794X211046430. [PMID: 34595332 DOI: 10.1177/2333794X211046430] [Reference Citation Analysis]
42 Warncke K. Nicht immer Typ 1 – seltene Diabetesformen bei Kindern. Monatsschr Kinderheilkd 2021;169:922-929. [DOI: 10.1007/s00112-021-01238-1] [Reference Citation Analysis]
43 van den Boom L, Stuecher T, Mader JK. Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail. Clin Case Rep 2021;9:e04811. [PMID: 34567554 DOI: 10.1002/ccr3.4811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Currie BM, Howell TA, Matza LS, Cox DA, Johnston JA. A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and Opportunities. Diabetes Ther 2021;12:2827-56. [PMID: 34554411 DOI: 10.1007/s13300-021-01136-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
45 Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes. CMAJ 2021;193:E1385-8. [PMID: 34493565 DOI: 10.1503/cmaj.202627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Akintayo-Usman NO, Okanlawon FA, Usman SO. Prevalence of pre-diabetes and risk factors among secondary school adolescents in Osogbo Local Government Area, Osun State, Nigeria. Afr Health Sci 2021;21:1301-9. [PMID: 35222595 DOI: 10.4314/ahs.v21i3.41] [Reference Citation Analysis]
47 Ramírez-Mejía MM, Díaz-Orozco LE, Barranco-Fragoso B, Méndez-Sánchez N. A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health. Med Sci Monit 2021;27:e934134. [PMID: 34456329 DOI: 10.12659/MSM.934134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
48 Lee J, Kim JH. Endocrine comorbidities of pediatric obesity. Clin Exp Pediatr 2021. [PMID: 34445852 DOI: 10.3345/cep.2021.00213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Grøndahl MFG, Johannesen J, Kristensen K, Knop FK. Treatment of type 2 diabetes in children: what are the specific considerations? Expert Opin Pharmacother 2021;22:2127-41. [PMID: 34420454 DOI: 10.1080/14656566.2021.1954160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Kahkoska AR, Dabelea D. Diabetes in Youth: A Global Perspective. Endocrinol Metab Clin North Am 2021;50:491-512. [PMID: 34399958 DOI: 10.1016/j.ecl.2021.05.007] [Reference Citation Analysis]
51 Calcaterra V, Verduci E, Pascuzzi MC, Magenes VC, Fiore G, Di Profio E, Tenuta E, Bosetti A, Todisco CF, D'Auria E, Zuccotti G. Metabolic Derangement in Pediatric Patient with Obesity: The Role of Ketogenic Diet as Therapeutic Tool. Nutrients 2021;13:2805. [PMID: 34444964 DOI: 10.3390/nu13082805] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Xu ZR, Du HW, Cui LW, Zheng RX, Li GM, Wei HY, Lu FY, Chen LL, Wu CS, Zhang SX, Zhang SL, Liu F, Zhang MY, Pei Z, Sun CJ, Wu J, Luo FH. Association of β-cell function and insulin resistance with pediatric type 2 diabetes among Chinese children. World J Diabetes 2021; 12(8): 1292-1303 [PMID: 34512894 DOI: 10.4239/wjd.v12.i8.1292] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
53 Shah AS, Helmrath MA, Inge TH, Xanthakos SA, Kelsey MM, Jenkins T, Trout AT, Browne L, Nadeau KJ. Study protocol: a prospective controlled clinical trial to assess surgical or medical treatment for paediatric type 2 diabetes (ST2OMP). BMJ Open 2021;11:e047766. [PMID: 34389568 DOI: 10.1136/bmjopen-2020-047766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lee YJ, Yoo S, Yi S, Kim S, Lee C, Cho J, Ahn S, Choi S, Hwang H, Lee YA, Shin CH, Yoon HJ, Kim K, Song E, Choi JH, Yoo HW, Kim YH, Oh JS, Kang EA, Baek GK, Kim JH. Trajectories in glycated hemoglobin and body mass index in children and adolescents with diabetes using the common data model. Sci Rep 2021;11:14614. [PMID: 34272437 DOI: 10.1038/s41598-021-94194-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Rami-merhar B, Jäger A, Fritsch M, Lück U, Fröhlich-reiterer E. Diagnose, Klassifikation, Epidemiologie. Paediatr Paedolog 2021;56:2-4. [DOI: 10.1007/s00608-021-00872-y] [Reference Citation Analysis]
56 Ahn MB, Cho KS, Kim SK, Kim SH, Cho WK, Jung MH, Suh JS, Suh BK. Poor Glycemic Control Can Increase the Plasma Kidney Injury Molecule-1 Concentration in Normoalbuminuric Children and Adolescents with Diabetes Mellitus. Children (Basel) 2021;8:417. [PMID: 34069734 DOI: 10.3390/children8050417] [Reference Citation Analysis]
57 Galderisi A, Moran A, Evans-Molina C, Martino M, Santoro N, Caprio S, Cobelli C. Early impairment of insulin sensitivity, β-cell responsiveness, and insulin clearance in youth with Stage 1 type 1 diabetes. J Clin Endocrinol Metab 2021:dgab344. [PMID: 34000022 DOI: 10.1210/clinem/dgab344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Tung JY, Kwan EY, But BW, Wong WH, Fu AC, Pang G, Tsang JW, Yau HC, Belaramani K, Wong LM, Wong SM, Lo P, Ng KL, Yeung WK, Chan KT, Chan AM, Wong SW, Tay MK, Chung J, Lee CY, Lam YY, Cheung PT. Incidence and clinical characteristics of pediatric-onset type 2 diabetes in Hong Kong: The Hong Kong childhood diabetes registry 2008 to 2017. Pediatr Diabetes 2021. [PMID: 33978300 DOI: 10.1111/pedi.13231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Rao G, Jensen ET. Type 2 Diabetes in Youth. Glob Pediatr Health 2020;7:2333794X20981343. [PMID: 34036121 DOI: 10.1177/2333794X20981343] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zabeen B, Maniam J, Balsa AMM, Tayyeb S, Huda K, Azad K, Ogle GD. Incidence of diabetes in children and adolescents in Dhaka, Bangladesh. J Pediatr Endocrinol Metab 2021;34:509-15. [PMID: 33662193 DOI: 10.1515/jpem-2020-0671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Jensen HK, Rasmussen L, Furu K, Karlstad Ø, Linder M, Cesta CE, Pottegård A. Use of non-insulin antidiabetic drugs in children and young adults - A Scandinavian drug utilization study from 2010-2019. Br J Clin Pharmacol 2021. [PMID: 33871080 DOI: 10.1111/bcp.14867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Serbis A, Giapros V, Kotanidou EP, Galli-Tsinopoulou A, Siomou E. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes 2021; 12(4): 344-365 [PMID: 33889284 DOI: 10.4239/wjd.v12.i4.344] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
63 Archibald MM, Dart A, Wicklow B, Pundyk KJ, Marks SD, Sellers EAC. Youth perceptions and experiences of type 2 diabetes: Protocol for a collaborative knowledge translation approach and qualitative study. J Adv Nurs 2021;77:3218-25. [PMID: 33855741 DOI: 10.1111/jan.14845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Reinehr T, Tittel SR, Holle R, Wiegand S, Gellhaus I, Hebebrand J, Greber-Platzer S, Denzer C, Linke S, Kiess W, Holl RW. Comparison of cardiovascular risk factors between children and adolescents with classes III and IV obesity: findings from the APV cohort. Int J Obes (Lond) 2021;45:1061-73. [PMID: 33828223 DOI: 10.1038/s41366-021-00773-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Koren D, Levitsky LL. Type 2 Diabetes Mellitus in Childhood and Adolescence. Pediatr Rev 2021;42:167-79. [PMID: 33795463 DOI: 10.1542/pir.2019-0236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
66 Homan M, Kovač J, Orel R, Battelino T, Kotnik P. Relevant Weight Reduction and Reversed Metabolic Co-morbidities Can Be Achieved by Duodenojejunal Bypass Liner in Adolescents with Morbid Obesity. Obes Surg 2020;30:1001-10. [PMID: 31758471 DOI: 10.1007/s11695-019-04279-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Cioana M, Deng J, Hou M, Nadarajah A, Qiu Y, Chen SSJ, Rivas A, Banfield L, Chanchlani R, Dart A, Wicklow B, Alfaraidi H, Alotaibi A, Thabane L, Samaan MC. Prevalence of Hypertension and Albuminuria in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA Netw Open 2021;4:e216069. [PMID: 33929524 DOI: 10.1001/jamanetworkopen.2021.6069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
68 Marcovecchio ML, Predieri B, De Filippo G, Delvecchio M. Editorial: Debates in Clinical Management in Pediatric Endocrinology. Front Endocrinol (Lausanne) 2021;12:663860. [PMID: 33776945 DOI: 10.3389/fendo.2021.663860] [Reference Citation Analysis]
69 Bensignor MO, Bomberg EM, Bramante CT, Divyalasya TVS, Hale PM, Ramesh CK, Rudser KD, Kelly AS. Effect of liraglutide treatment on body mass index and weight parameters in children and adolescents with type 2 diabetes: Post hoc analysis of the ellipse trial. Pediatr Obes 2021;16:e12778. [PMID: 33634589 DOI: 10.1111/ijpo.12778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
70 Lamminsalo A, Lundqvist A, Virta LJ, Gissler M, Kaila M, Metsälä J, Virtanen SM. Cow's milk allergy in infancy and later development of type 1 diabetes-nationwide case-cohort study. Pediatr Diabetes 2021;22:400-6. [PMID: 33470004 DOI: 10.1111/pedi.13181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Gurunathan U, Prasad HK, White S, Sangalalingam T, Krishnamoorthy N. Type 2 Diabetes Mellitus in Adolescents From Southern India — A Single Center Experience. Indian Pediatr 2021;58:176-177. [DOI: 10.1007/s13312-021-2135-4] [Reference Citation Analysis]
72 Regelmann MO, Conroy R, Gourgari E, Gupta A, Guttmann-Bauman I, Heksch R, Kamboj MK, Krishnan S, Lahoti A, Matlock K; PES Drug and Therapeutics Committee and Practice Management Committee. Pediatric Endocrinology in the Time of COVID-19: Considerations for the Rapid Implementation of Telemedicine and Management of Pediatric Endocrine Conditions. Horm Res Paediatr 2020;93:343-50. [PMID: 33486483 DOI: 10.1159/000513060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
73 Middleton T, Constantino M, Mcgill M, D'souza M, Twigg SM, Wu T, Thiagalingam A, Chow C, Wong J. An Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial (Preprint).. [DOI: 10.2196/preprints.27263] [Reference Citation Analysis]
74 Gow ML, Pham-Short A, Jebeile H, Varley BJ, Craig ME. Current Perspectives on the Role of Very-Low-Energy Diets in the Treatment of Obesity and Type 2 Diabetes in Youth. Diabetes Metab Syndr Obes 2021;14:215-25. [PMID: 33500642 DOI: 10.2147/DMSO.S238419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
75 Singhal S, Kumar S. Current Perspectives on Management of Type 2 Diabetes in Youth. Children (Basel) 2021;8:37. [PMID: 33435250 DOI: 10.3390/children8010037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
76 Sperling MA, Wolfsdorf JI, Menon RK, Tamborlane WV, Maahs D, Battelino T, Phillip M. Diabetes Mellitus. Sperling Pediatric Endocrinology 2021. [DOI: 10.1016/b978-0-323-62520-3.00021-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Ludwig K, Craig ME, Donaghue KC, Maguire A, Benitez‐aguirre PZ; The ADDN Study Group. Type 2 diabetes in children and adolescents across Australia and New Zealand: A 6‐year audit from The Australasian Diabetes Data Network (ADDN). Pediatr Diabetes 2021;22:380-7. [DOI: 10.1111/pedi.13169] [Reference Citation Analysis]
78 Meyers AG, Hudson J, Cravalho CKL, Matta ST, Villalobos-Perez A, Cogen F, Chung ST. Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center. Pediatr Diabetes 2021;22:182-91. [PMID: 33179823 DOI: 10.1111/pedi.13148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Nwosu BU, Villalobos-Ortiz TR, Jasmin GA, Parajuli S, Zitek-Morrison E, Barton BA. Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes. J Pediatr Endocrinol Metab 2020;33:1399-408. [PMID: 33027052 DOI: 10.1515/jpem-2020-0220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
80 Veyder-malberg C, Furthner D, Dalus C, Maruszczak K, Schneider A, Weghuber D. GLP-1-Analoga in der Therapie des Typ-2-Diabetes bei Jugendlichen. Monatsschr Kinderheilkd 2021;169:253-7. [DOI: 10.1007/s00112-020-01073-w] [Reference Citation Analysis]
81 Sun JW, Hernández‐díaz S, Bourgeois FT, Haneuse S, Brill G, Bateman BT, Huybrechts KF. Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019. Diabetes Obes Metab 2021;23:444-54. [DOI: 10.1111/dom.14237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
82 Lynch JL, Barrientos-Pérez M, Hafez M, Jalaludin MY, Kovarenko M, Rao PV, Weghuber D. Country-Specific Prevalence and Incidence of Youth-Onset Type 2 Diabetes: A Narrative Literature Review. Ann Nutr Metab 2020;76:289-96. [PMID: 32980841 DOI: 10.1159/000510499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
83 Galderisi A, Tricò D, Dalla Man C, Santoro N, Pierpont B, Groop L, Cobelli C, Caprio S. Metabolic and Genetic Determinants of Glucose Shape After Oral Challenge in Obese Youths: A Longitudinal Study. J Clin Endocrinol Metab 2020;105:dgz207. [PMID: 31972003 DOI: 10.1210/clinem/dgz207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
84 Sunil B, Ashraf AP. Dyslipidemia in Pediatric Type 2 Diabetes Mellitus. Curr Diab Rep 2020;20:53. [PMID: 32909078 DOI: 10.1007/s11892-020-01336-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
85 Soliman A, De Sanctis V, Alaaraj N, Hamed N. The clinical application of metformin in children and adolescents: A short update. Acta Biomed 2020;91:e2020086. [PMID: 32921782 DOI: 10.23750/abm.v91i3.10127] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
86 Bismuth-reisman E. Le diabète de type 2 chez l’enfant et l’adolescent. Médecine des Maladies Métaboliques 2020;14:401-407. [DOI: 10.1016/j.mmm.2020.06.007] [Reference Citation Analysis]
87 Chang N, Yeh MY, Raymond JK, Geffner ME, Ryoo JH, Chao LC. Glycemic control in youth-onset type 2 diabetes correlates with weight loss. Pediatr Diabetes 2020;21:1116-25. [PMID: 33103329 DOI: 10.1111/pedi.13093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
88 Orozco Morales JA, Medina Urrutia AX, Torres Tamayo M, Jorge Galarza E, Reyes Barrera J, Díes Suarez P, Juárez Rojas JG, Medina-Bravo P. Effects of fatty liver on the size and composition of high-density lipoprotein cholesterol subpopulations in adolescents with type 2 diabetes mellitus. Pediatr Diabetes 2020;21:1140-9. [PMID: 32812688 DOI: 10.1111/pedi.13103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Serbis A, Giapros V, Galli-Tsinopoulou A, Siomou E. Metabolic Syndrome in Children and Adolescents: Is There a Universally Accepted Definition? Metab Syndr Relat Disord. 2020;18:462-470. [PMID: 32795106 DOI: 10.1089/met.2020.0076] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
90 Pleniceanu O, Twig G, Tzur D, Gruber N, Stern-zimmer M, Afek A, Erlich T, Keinan-boker L, Skorecki K, Calderon-margalit R, Vivante A. Kidney failure risk in type 1 vs. type 2 childhood-onset diabetes mellitus. Pediatr Nephrol 2021;36:333-40. [DOI: 10.1007/s00467-020-04631-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
91 Siller AF, Tosur M, Relan S, Astudillo M, Mckay S, Dabelea D, Redondo MJ. Challenges in the diagnosis of diabetes type in pediatrics. Pediatr Diabetes 2020;21:1064-73. [DOI: 10.1111/pedi.13070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
92 Vidmar AP, Goran MI, Naguib M, Fink C, Wee CP, Hegedus E, Lopez K, Gonzalez J, Raymond JK. Time limited eating in adolescents with obesity (time LEAd): Study protocol. Contemp Clin Trials 2020;95:106082. [PMID: 32682994 DOI: 10.1016/j.cct.2020.106082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
93 Hou L, Ge L, Li Y, Chen Y, Li H, He J, Cao C, Li R, Tian J, Chen Y, Liu X, Yang K. Physical activity recommendations for patients with type 2 diabetes: a cross-sectional survey. Acta Diabetol 2020;57:765-77. [PMID: 32025878 DOI: 10.1007/s00592-020-01480-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
94 Graves LE, Donaghue KC. Vascular Complication in Adolescents With Diabetes Mellitus. Front Endocrinol (Lausanne) 2020;11:370. [PMID: 32582034 DOI: 10.3389/fendo.2020.00370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
95 Peña AS, Curran JA, Fuery M, George C, Jefferies CA, Lobley K, Ludwig K, Maguire AM, Papadimos E, Peters A, Sellars F, Speight J, Titmuss A, Wilson D, Wong J, Worth C, Dahiya R. Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines. Med J Aust 2020;213:30-43. [PMID: 32578226 DOI: 10.5694/mja2.50666] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
96 Peterkova VA, Shestakova MV, Bezlepkina OB, Laptev DN, Kuraeva TL, Mayorov AY, Titovich EV, Emelyanov AO, Svetlova GN, Eremina IA, Alimova IL, Bashnina EB, Bolotova NV, Galkina GA, Kostrova IB, Мalievsky OA, Petriaikina EE, Samsonova LN, Khramova EB. Diabetes mellitus type 1 in childhood. Diabetes mellitus 2020;23:4-40. [DOI: 10.14341/dm12504] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
97 Reinehr T. Diagnostik und Therapie bei Adipositas und extremer Adipositas im Kindes- und Jugendalter. Pädiatrie up2date 2020;15:107-125. [DOI: 10.1055/a-0964-3233] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
98 Mengen E, Uçaktürk SA. Evaluation of the relationship between the one-hour plasma glucose concentration and beta-cell functions and cardiometabolic parameters during oral glucose tolerance test in obese children and adolescents. J Pediatr Endocrinol Metab 2020;33:767-75. [PMID: 32447335 DOI: 10.1515/jpem-2020-0016] [Reference Citation Analysis]
99 Vajravelu ME, Lee JM, Shah R, Shults J, Amaral S, Kelly A. Association between prediabetes diagnosis and body mass index trajectory of overweight and obese adolescents. Pediatr Diabetes 2020;21:743-6. [PMID: 32314478 DOI: 10.1111/pedi.13028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Band ME. Sugar Babies. Physician Assistant Clinics 2020;5:237-46. [DOI: 10.1016/j.cpha.2019.11.007] [Reference Citation Analysis]
101 Lee KA. Management of Type 2 Diabetes Mellitus in Adolescents and Young Adults. J Korean Diabetes 2020;21:6-10. [DOI: 10.4093/jkd.2020.21.1.6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
102 Barrett T, Jalaludin MY, Turan S, Hafez M, Shehadeh N; Novo Nordisk Pediatric Type 2 Diabetes Global Expert Panel. Rapid progression of type 2 diabetes and related complications in children and young people-A literature review. Pediatr Diabetes 2020;21:158-72. [PMID: 31804738 DOI: 10.1111/pedi.12953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
103 Shah AS, Nadeau KJ. The changing face of paediatric diabetes. Diabetologia. 2020;63:683-691. [PMID: 31897525 DOI: 10.1007/s00125-019-05075-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
104 Lange K, Ernst G. Psychologische und pädagogische Elemente der Langzeitbehandlung bei Kindern und Jugendlichen mit chronischen Erkrankungen. Pädiatrische Endokrinologie und Diabetologie 2020. [DOI: 10.1007/978-3-662-57309-9_8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Fisher LK, Vidmar AP. Health Care, Insurance, and School Policy Affecting Diabetes in the Pediatric Population. Behavioral Diabetes 2020. [DOI: 10.1007/978-3-030-33286-0_16] [Reference Citation Analysis]
106 Kim G, Hang T, Laroche A. Type II Diabetes Mellitus. Adolescent Nutrition 2020. [DOI: 10.1007/978-3-030-45103-5_23] [Reference Citation Analysis]
107 Majeed NA, Shiruhana SA, Maniam J, Eigenmann CA, Siyan A, Ogle GD. Incidence, prevalence and mortality of diabetes in children and adolescents aged under 20 years in the Republic of Maldives. J Paediatr Child Health 2020;56:746-50. [DOI: 10.1111/jpc.14726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
108 Al-Kandari H, Al-Abdulrazzaq D, Davidsson L, Sharma P, Al-Tararwa A, Mandani F, Al-Shawaf F, Al-Hussaini F, Qabazard M, Haddad D, Al-Mahdi M, Al-Jasser F, Al-Anzi A, Al-Sanea H, Al-Basari I, Al-Adsani A, Shaltout A, AbdulRasoul M. Incidence of Type 2 Diabetes in Kuwaiti Children and Adolescents: Results From the Childhood-Onset Diabetes Electronic Registry (CODeR).Front Endocrinol (Lausanne). 2019;10:836. [PMID: 31866943 DOI: 10.3389/fendo.2019.00836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
109 Nur Zati Iwani AK, Jalaludin MY, Wan Mohd Zin RM, Fuziah MZ, Hong JYH, Abqariyah Y, Mokhtar AH, Wan Mohamud WN. TG : HDL-C Ratio Is a Good Marker to Identify Children Affected by Obesity with Increased Cardiometabolic Risk and Insulin Resistance. Int J Endocrinol 2019;2019:8586167. [PMID: 31885562 DOI: 10.1155/2019/8586167] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
110 Abe Y, Urakami T, Hara M, Yoshida K, Mine Y, Aoki M, Suzuki J, Saito E, Yoshino Y, Iwata F, Okada T, Morioka I. The Characteristics Of Abdominal Fat Distribution In Japanese Adolescents With Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes 2019;12:2281-8. [PMID: 31807041 DOI: 10.2147/DMSO.S223049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
111 Kapellen TM. Pharmacotherapy of Children and Adolescents with Type 2 Diabetes Mellitus. Handb Exp Pharmacol 2020;261:119-29. [PMID: 31628599 DOI: 10.1007/164_2019_266] [Reference Citation Analysis]
112 Fornari E, Maffeis C. Treatment of Metabolic Syndrome in Children. Front Endocrinol (Lausanne) 2019;10:702. [PMID: 31681173 DOI: 10.3389/fendo.2019.00702] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
113 Ambler G, Cameron F, Joshi K, Wherrett D. Diabetes Mellitus. Brook's Clinical Pediatric Endocrinology 2019. [DOI: 10.1002/9781119152712.ch15] [Reference Citation Analysis]
114 Kapellen T. Typ-2-Diabetes bei Kindern ist für Diabetologen eine harte Nuss. Pädiatrie 2019;31:30-39. [DOI: 10.1007/s15014-019-1500-4] [Reference Citation Analysis]
115 Mengen E, Uçaktürk SA, Kocaay P, Kaymaz Ö, Neşelioğlu S, Erel Ö. The Significance of Thiol/Disulfide Homeostasis and Ischemia-modified Albumin Levels in Assessing Oxidative Stress in Obese Children and Adolescents. J Clin Res Pediatr Endocrinol 2020;12:45-54. [PMID: 31414586 DOI: 10.4274/jcrpe.galenos.2019.2019.0039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
116 Graves LE, Donaghue KC. Management of diabetes complications in youth. Ther Adv Endocrinol Metab. 2019;10:2042018819863226. [PMID: 31384418 DOI: 10.1177/2042018819863226] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
117 Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes Metab Syndr Obes 2019;12:1047-56. [PMID: 31360071 DOI: 10.2147/DMSO.S179793] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 20.5] [Reference Citation Analysis]
118 Songer TJ, Haymond MW, Glazner JE, Klingensmith GJ, Laffel LM, Zhang P, Hirst K; TODAY Study Group. Healthcare and associated costs related to type 2 diabetes in youth and adolescence: the TODAY clinical trial experience. Pediatr Diabetes 2019;20:702-11. [PMID: 31119838 DOI: 10.1111/pedi.12869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
119 Zeitler P. Progress in understanding youth-onset type 2 diabetes in the United States: recent lessons from clinical trials. World J Pediatr 2019;15:315-21. [DOI: 10.1007/s12519-019-00247-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
120 Xu ZR, Zhang MY, Ni JW, Cheng RQ, Zheng ZQ, Xi L, Luo FH. Clinical characteristics and beta-cell function of Chinese children and adolescents with type 2 diabetes from 2009 to 2018. World J Pediatr. 2019;15:405-411. [PMID: 30911992 DOI: 10.1007/s12519-019-00243-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
121 Codner E, Acerini CL, Craig ME, Hofer SE, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: What is new in diabetes care? Pediatr Diabetes 2018;19:5-6. [DOI: 10.1111/pedi.12759] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
122 Lange K, Ernst G. Psychologische und pädagogische Elemente der Langzeitbehandlung bei Kindern und Jugendlichen mit chronischen Erkrankungen. Pädiatrische Endokrinologie und Diabetologie 2018. [DOI: 10.1007/978-3-662-52794-8_8-1] [Reference Citation Analysis]